Selective growth story; revenue upsell masks margin compression

Delivered result: INR1,151.9 Cr (21.1% YoY). Management reported only ~68% of consolidated revenue

Delivered PAT INR26.5 Cr (49.7% growth). Margin compressed to 2.3% consolidated vs 4% on reported revenue

At 89% utilization with strong capacity leverage; guidance reaffirmed but contingent on commodity hedging strategy

Numbers cited; segment still at -INR13 Cr EBITDA as management invests for scale. Acceptable per guidance

Articulated but no independent verification; UP scale narrative credible given market size (95 lakh cases/month)

Reaffirmed INR5-7/L; Q1 delivered INR6.5/L. No change vs prior guidance, but 89% utilization (vs 85% guidance) signals tighter headroom.

Geographic footprint expanded to 11 states (up from 7 last reported); 4 core states (Delhi, UP, Rajasthan, and 1 unnamed), 6 moving-to-core, 1 early-luxury. FY29 target 500 Cr P&A revenue (vs prior FY29 vision statement vague).

Crossed 0.2M cases/month (vs ~0 baseline 12 months ago). 2.4x volume growth YoY is material; mgmt called it 'next big bankable opportunity'.

Margins expected to normalize from 17-18% (Rajasthan-heavy) to 15-17% due to UP mix (lower-margin market structure). Mix-driven, not inflation-driven.

E20 core demand ~7-7.5% (aligned with petrol growth); no material impact from controversy. Ethanol offtake 'sticky'. Facility flexibility (ENA/ethanol mix + international sales) allows 89% utilization despite oversupply.

Difficult to quantify per-quarter; UP market 95 lakh cases/month, we're aggressive. FY29 guidance given, not quarterly splits. Team executing at fastest pace.

States flow between emerging and core dynamically; benchmarks shift. Core states cross profitability threshold year-3 post-launch. Now 5 core, 6th knocking, target 10 core eventually.

R&O/P&A cost-pass strategy not detailed; general statement: aggressive growth helps absorb. Energy prices embedded across business.

Margins will normalize to 15-16% from 17-18% due to UP mix; guidance stands. Doesn't structurally impact business.

Different states prefer different categories (vodka, semi-premium, deluxe). Geographic expansion drives this naturally. No brand in distress; growth is broad-based.

Expect tailwind as inventory transitions, but timing vague. Base price changes by suppliers yet to be seen. FX headwind (Rupee -20% vs Pound YoY) offsets most gains.

On final regulatory hurdle; reasonable view clearance this quarter. Within 60 days of approval, back in market. Market environment neutral to positive.

No capacity expansion capex planned through FY29. Only ~50-60 Cr/year maintenance capex. 1% incremental capacity possible from tech improvements.

Multi-legged: FCI fixed-price supply (portion), maize futures hedge, ENA flex-pricing. Broken rice unhedged but seasonal. Confident on INR5-7/L guidance.

Management focused on segment narratives (13% growth in core business) without consolidated target. Implies flexibility or lack of comfort with full-year outlook.

Achieved INR6.5/L in Q1 at 89% utilization. Multi-legged hedge strategy (FCI fixed supply, maize futures, ENA flex-pricing) provides confidence.

Mix-driven normalization (UP entry with lower-margin structure). Rajasthan stable; UP will drag composite margin slightly but market opportunity large.

UP facility commissioned; no new plants planned. Incremental capacity via tech improvements (1% upside). All cash generated available for P&A growth or debt pay-down.

Glass/PET costs up 10-17%; raw material inflation in Q2/Q3 seasonal; consolidated NPM already compressed to 2.3% (vs 4% on core business). Pass-through ability unproven at scale.

363 Cr (32%) of consolidated revenue not attributed to discussed segments; implied sub-1% margin. Raises questions on data quality, segment definition, or undisclosed low-margin businesses.

P&A EBITDA negative INR13 Cr despite 35% revenue growth; breakeven timeline not disclosed. If premium brand scaling doesn't achieve 15%+ margins within 2-3 yrs, capex/investment thesis collapses.

UP R&O claimed 2.4x volume growth to 0.2M cases/month in massive market (95 lakh/month). Mgmt refused to quantify forward growth ('very difficult'). Risk: growth rate normalizes faster than expected if market saturation or competitive response hits.

UK FTA expected to lower Scotch tariffs, but Rupee depreciation (20% vs Pound YoY) offsets gains. Mgmt said net impact 'not very significant'. Inventory transition timelines vague.